Overview
Lobbying Costs
75,000€
Financial year: Feb 2017 - Dec 2017
Lobbyists (Full time equivalent)
0.75 Fte (2)
Lobbyists with EP accreditation
0
High-level Commission meetings
1
Lobbying Costs over the years
-
Info
Medtech & Pharma Platform (MPP)
EU Transparency Register
234427831877-10 First registered on 25 Jun 2018
Goals / Remit
The Medtech & Pharma Platform is an industry association using the synergies between medtech and pharmaceutical companies by establishing a forum to exchange knowledge and collaborate in technology and regulatory areas, as well as to promote product development and innovation.
Future innovative healthcare solutions increasingly rely on combined products from pharma and medtech companies. Collaboration between both industries is therefore key to future innovations.
The association’s goals are
• Establish new industry collaboration models to ensure and accelerate market access for safe and innovative treatment options in the field of combined products.
• Manage the interface between industry, policy makers, regulators and notified bodies and foster an open and transparent dialogue.
• Provide a platform for joint work on a balanced and proportionate regulatory and political framework for combined products that
o facilitates innovation for the European market, it’s industries and citizens
o strengthens public health through improved patients’ access to innovative products
o reduces time to market for drugs, devices and combinations thereof
o promotes free trade and IP principles
Medtech & Pharm Platform acts with a global mindset but initially focusses on European policy developments.Main EU files targeted
The Medtech & Pharma Platform Association was founded in 2017 and started its activities in 2018.
The Medtech & Pharma Platform monitors all EU legislative, policy and regulatory developments relating to combined products.
Specifically the Medtech & Pharm Platform follows:
• Medical Device Regulation EU 2017/745 and it implementing and delegated acts as well as any related guidance document
• In vitro Diagnostic Regulation EU 2017/746
• Medicinal Product Directive EU 2001/83
• Proposal for a Regulation on Health Technology
Assessment
• General Data Protection Regulation EU 2016/679
• Clinical Trials Regulation EU 536/2014
• Policy initiatives, projects, events and publications from DG SANTE, DG GROW, DG CONNECT, DG RESEARCH
• Horizon 2020 / Horizon EuropeAddress
Head Office
Medtech & Pharma Platform
c/o SFL Regulatory Affairs & Scientific Communication GmbH
Basel 4053
SWITZERLAND -
People
Total lobbyists declared
2
Employment time Lobbyists 50% 1 25% 1 Lobbyists (Full time equivalent)
0.75
Lobbyists with EP accreditation
No lobbyists with EP accreditations
Complementary Information
Within the cluster of 25% working time there are two persons which together work 25 %.
Person in charge of EU relations
Ms Shayesteh Fürst-Ladani (MPP President)
Person with legal responsibility
Ms Shayesteh Fürst-Ladani (MPP President)
-
Categories
Category
II - In-house lobbyists and trade/business/professional associations
Subcategory
Trade and business associations
-
Networking
Affiliation
n.a.
Member organisations
https://www.medtech-pharma.com/home/
-
Financial Data
Closed financial year
Feb 2017 - Dec 2017
Lobbying costs for closed financial year
75,000€
Other financial info
MPP is funded by membership contributions
-
EU Structures
Groups (European Commission)
none
Groups (European Parliament)
None
Communication activities
None
Other activities
None declared
- Meetings
Meetings
1 meetings found. Download meetings
The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't proactively publish information about these meetings. For more information about which commissioner is responsible for which portfolio, check out this link: https://commissioners.ec.europa.eu/index_en All information below comes from European Commission web pages.
-
Date 15 Jun 2018 Location Brussels, Berl Subject HTA Cabinet Cabinet of Commissioner Vytenis Andriukaitis Portfolio Health & Food Safety Attending - Vytenis Andriukaitis (Commissioner)
- Annika Nowak (Cabinet member)
Other Lobbyists - European Coordination Committee of the Radiological, Electromedical and healthcare IT Industry
- MEDICINES FOR EUROPE
- Association of the European Self-Care Industry
- European Confederation of Pharmaceutical Entrepreneurs
- MedTech Europe
- European Federation of Pharmaceutical Industries and Associations
- Plasma Protein Therapeutics Association Europe, international Association without lucrative purpose
- EuropaBio
- European Plastics Converters Association
- Meetings